ELDN Hedge Fund Ownership (Q2 2026)

Eledon Pharmaceuticals Inc (ELDN)

156 + Investors. Track Smart Money conviction in ELDN. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ELDN

Based on 156 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

156 hedge funds hold ELDN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +84% more funds vs a year ago

fund count last 6Q

+71 new funds entered over the past year (+84% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 74% buying

108 buying37 selling

Last quarter: 108 funds were net buyers (47 opened a brand new position + 61 added to an existing one). Only 37 were sellers (25 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~47 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 21 → 32 → 43 → 47. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 56% entered in last year

■ 19% conviction (2yr+) ■ 26% medium ■ 56% new

Only 29 funds (19%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +45% but shares only +12% — price-driven

Value

+45%

+11%

Last quarter: the total dollar value of institutional holdings rose +45%, but actual share count only changed +12%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

28 → 21 → 32 → 43 → 47 new funds/Q

New funds entering each quarter: 21 → 32 → 43 → 47. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 67% of holders entered in last year

■ 24% veterans ■ 9% 1-2yr ■ 67% new

Of 162 current holders: 109 (67%) entered in the past year, only 39 (24%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 38% AUM from major funds

38% from top-100 AUM funds

37 of 156 holders rank in the top 100 by AUM, accounting for 38% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

5.6

out of 10

Moderate Exit Risk

Exit risk score 5.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	156	121	28.93%
13F Shares	48M	43M	11.82%
Total Value	$187M	$129M	45.02%
New Positions	47	43	+4
Increased Positions	61	33	+28
Closed Positions	12	16	-4
Reduced Positions	22	22	-
Total Calls	3	2	50.0%
Total Puts	3	0	100%
PUT/CALL Ratio	1.0	0.0	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

156

121

28.93%

13F Shares

48M

43M

11.82%

Total Value

$187M

$129M

45.02%

New Positions

Increased Positions

+28

Closed Positions

-4

Reduced Positions

Total Calls

50.0%

Total Puts

100%

PUT/CALL Ratio

1.0

0.0

Neutral

Institutional Holders (2026 Q2)

156 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ELDN. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ELDN holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	22nw, LP	2.40%	636,364	$2.5M
2	Defilade Capital Management, L.P.	1.86%	3,525,338	$13.9M
3	CM Management, LLC	1.44%	575,000	$2.3M
4	Catalio Capital Management, LP	1.26%	1,695,071	$6.7M
5	Bvf Inc/Il	0.63%	6,293,282	$24.8M
6	Sphera Funds Management LTD.	0.61%	1,191,187	$4.7M
7	Kingdon Capital Management, L.L.C.	0.42%	1,039,275	$4.1M
8	AWM Investment Company, Inc.	0.38%	1,100,000	$4.3M
9	Blue Owl Capital Holdings LP	0.34%	566,509	$2.2M
10	Daytona Street Capital LLC	0.23%	81,166	$313K
11	Triumph Capital Management	0.22%	303,443	$1.2M
12	Zimmer Partners, LP	0.14%	1,596,599	$6.3M
13	ADAR1 Capital Management, LLC	0.12%	647,812	$2.6M
14	Prodigy Asset Management LLC	0.10%	86,703	$342K
15	Scientech Research LLC	0.07%	22,844	$90K
16	PW Nova Financial Services LLC	0.05%	58,041	$229K
17	BIT Capital GmbH	0.03%	266,000	$1.0M
18	Split Rock Private Trading & Wealth Management, LLC	0.03%	10,000	$39K
19	GK Wealth Management LLC	0.02%	11,487	$45K
20	Shay Capital LLC	0.02%	64,000	$252K
21	Kera Capital Partners, Inc.	0.02%	40,208	$158K
22	Ensign Peak Advisors, Inc	0.01%	2,101,224	$8.3M
23	Howard Financial Services, LTD.	0.01%	30,000	$118K
24	Navellier & Associates Inc	0.01%	35,925	$142K
25	Brevan Howard Capital Management LP	0.01%	304,707	$1.2M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Eledon Pharmaceuticals Inc (ELDN)

What does the Smart Money Trend signal show for ELDN?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ELDN?

More buyers than sellers — 74% buying: Last quarter: 108 funds were net buyers (47 opened a brand new position + 61 added to an existing one). Only 37 were sellers (25 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ELDN holders?

Strong quality — 38% AUM from major funds: 37 of 156 holders rank in the top 100 by AUM, accounting for 38% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ELDN?

Mostly new holders — 56% entered in last year: Only 29 funds (19%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Eledon Pharmaceuticals Inc (ELDN)

Smart Money Signals — ELDN

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +84% more funds vs a year ago

More buyers than sellers — 74% buying

Steady new buyers — ~47 new funds per quarter

Mostly new holders — 56% entered in last year

Value +45% but shares only +12% — price-driven

Acceleration phase — new buyers rushing in

Early stage — 67% of holders entered in last year

Strong quality — 38% AUM from major funds

Institutional Sentiment Summary — ELDN

Hedge Fund Ownership: ELDN

Market Analysis: ELDN

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ELDN

Hedge Fund Positioning: ELDN

Statistics: ELDN

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Eledon Pharmaceuticals Inc (ELDN)

Welcome to 13Foresight!